January
सोमंबुगुशुशनिर
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
February
सोमंबुगुशुशनिर
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
March
सोमंबुगुशुशनिर
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
April
सोमंबुगुशुशनिर
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
May
सोमंबुगुशुशनिर
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
June
सोमंबुगुशुशनिर
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
July
सोमंबुगुशुशनिर
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
August
सोमंबुगुशुशनिर
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
September
सोमंबुगुशुशनिर
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
October
सोमंबुगुशुशनिर
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
November
सोमंबुगुशुशनिर
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
December
सोमंबुगुशुशनिर
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
घटना घनत्व:
1-5
6-9
10-12
13+
2017 में घटनाएँ
—
2017: First Gene Therapy Approved (Luxturna) (2017)
Landmark Approval
Luxturna proved that an AAV vector could deliver a functional gene in vivo and restore meaningful physiological function in a …
—
2017: First CAR-T Approved (Kymriah) (2017)
Landmark Approval
Kymriah's approval established [[term:car-t-cell-therapy|CAR-T cell therapy]] as a commercial medical product, creating the first approved gene therapy for cancer and …